Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Rinvoq (upadacitinib) - AbbVie
Olumiant (baricitinib) - Incyte, Eli Lilly
Sotyktu (deucravacitinib) - BMS
The future of lupus treatment is oral therapies? (RheumNow) - Jun 1, 2023 - "Importantly, several drug approvals in lupus have occurred recently: belimumab (high dose) for lupus nephritis, anifrolimumab for non-renal SLE, and in glomerulonephritis in lupus there is a phase 3 high dose anifrolimumab where results won't be available for a couple of years. Voclosporin can benefit nephritis in addition to standard of care." 
Online posting
https://rheumnow.com/news/future-lupus-treatment-oral-therapies
 
Jun 1, 2023
 
Prev Next